DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ML-246
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ML-246
×
Maximum Phase:
1
First Approval:
None
UNII:
Q6A9F9DSX5
Molecule Type:
Small molecule
Molecular Formula:
C31H30N4O
Molecular Weight:
474.61
AlogP:
6.18
PSA:
66.83
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CX-5461
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
CX-5461
×
Maximum Phase:
1
First Approval:
None
UNII:
3R4C5YLB9I
Molecule Type:
Small molecule
Molecular Formula:
C27H27N7O2S
Molecular Weight:
513.63
AlogP:
3.23
PSA:
95.73
HBD:
1.0
HBA:
#RotB:
4.0
Source:
VX-853
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VX-853
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
AZD-1208
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma; Neoplasms
Serine/threonine-protein kinase PIM inhibitor
AZD-1208
×
Maximum Phase:
1
First Approval:
None
UNII:
S98NFM1378
Molecule Type:
Small molecule
Molecular Formula:
C21H21N3O2S
Molecular Weight:
379.49
AlogP:
3.61
PSA:
75.43
HBD:
2.0
HBA:
#RotB:
3.0
Source:
IMC-1C11
1
Antibody
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor 2 inhibitor
IMC-1C11
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SB-756050
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
SB-756050
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H28N2O8S2
Molecular Weight:
500.6
AlogP:
1.81
PSA:
111.68
HBD:
0.0
HBA:
#RotB:
8.0
Source:
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
VORSETUZUMAB MAFODOTIN
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Renal Cell
CD70 antigen binding agent
VORSETUZUMAB MAFODOTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
699619YVTQ
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
FLUOROACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLUOROACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
AP1JV9U41M
Molecule Type:
Small molecule
Molecular Formula:
C2H3FO2
Molecular Weight:
78.04
AlogP:
0.04
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BAY-1082439
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase p110-alpha subunit inhibitor
BAY-1082439
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RO6895882
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
RO6895882
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIROCAFTOR
1
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
DIROCAFTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
2G3T6M1AS9
Molecule Type:
Small molecule
Molecular Formula:
C22H28N2O3Si2
Molecular Weight:
424.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SIZOFIRAN
1
Unknown
Investigational
Unknown
Unknown
Uterine Cervical Neoplasms
Unknown
SIZOFIRAN
×
Maximum Phase:
1
First Approval:
None
UNII:
7F763NNC9X
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IRSOGLADINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IRSOGLADINE
×
Maximum Phase:
1
First Approval:
None
UNII:
QBX79NZC1D
Molecule Type:
Small molecule
Molecular Formula:
C9H7Cl2N5
Molecular Weight:
256.1
AlogP:
2.01
PSA:
90.71
HBD:
2.0
HBA:
#RotB:
1.0
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
RX-3117
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RX-3117
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IT-139
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
IT-139
×
Maximum Phase:
1
First Approval:
None
UNII:
7OSJ9KS483
Molecule Type:
Small molecule
Molecular Formula:
C14H12Cl4N4NaRu
Molecular Weight:
502.15
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AVOTACICLIB
1
Small molecule
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Unknown
AVOTACICLIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C13H11N7O
Molecular Weight:
281.28
AlogP:
0.87
PSA:
136.72
HBD:
3.0
HBA:
#RotB:
2.0
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
BTA-9881
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
BTA-9881
×
Maximum Phase:
1
First Approval:
None
UNII:
9VR1J6U4XG
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClN4O2
Molecular Weight:
390.83
AlogP:
2.94
PSA:
66.4
HBD:
0.0
HBA:
#RotB:
2.0
Source:
VT-1598
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
VT-1598
×
Maximum Phase:
1
First Approval:
None
UNII:
AV9K9X720D
Molecule Type:
Small molecule
Molecular Formula:
C31H20F4N6O2
Molecular Weight:
584.53
AlogP:
4.88
PSA:
109.74
HBD:
1.0
HBA:
#RotB:
8.0
Source:
RG-7795
1
Unknown
Investigational
Unknown
Unknown
Hepatitis C
Unknown
RG-7795
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NANATINOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
NANATINOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
YTL7A418KQ
Molecule Type:
Small molecule
Molecular Formula:
C20H19FN6O2
Molecular Weight:
394.41
AlogP:
1.51
PSA:
103.27
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TAK-915
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TAK-915
×
Maximum Phase:
1
First Approval:
None
UNII:
0M4DME62Y9
Molecule Type:
Small molecule
Molecular Formula:
C19H18F4N4O5
Molecular Weight:
458.37
AlogP:
2.98
PSA:
102.02
HBD:
2.0
HBA:
#RotB:
6.0
Source:
MP-412
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
MP-412
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-369796
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
GSK-369796
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClN3O
Molecular Weight:
355.87
AlogP:
5.23
PSA:
57.18
HBD:
3.0
HBA:
#RotB:
4.0
Source:
1
2
…
85
86
87
88
89
90
91
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA